This study called for male subjects, age 40 or older, residing in the U.S. – who accumulated a score of eight (or greater) on the self-administered International Prostate Symptom Score (I-PSS) questionnaire (used to analyze LUTS). Participants were recruited by way of online advertisements which linked to a landing page explaining both the clinical trial and treatment product in detail. Interested subjects were then invited to access ClaimIt™, ObvioHealth’s application used to conduct studies digitally, where they could review/sign an electronic informed consent (eIC) form before being considered for enrollment. Being a remote study, subjects weren’t required to visit a physical site during screening but were instead asked to fill out a screening and medical history e-questionnaire. After enrollment, subjects were asked to consume one capsule of the manufacturer’s supplement each day for twelve consecutive weeks, and to report any noticeable changes to their health.